Clinical Trial: A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Comparison of Olopatadine Versus Fluticasone Nasal Spray in the Prevention of the Signs and Symptoms of Allergic Conjunctivitis

Brief Summary: To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

Detailed Summary: Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular anti-allergic therapy in the prevention of ocular allergic symptoms.
Sponsor: Greiner, Jack V., OD DO PhD

Current Primary Outcome: Ocular itching [ Time Frame: Minutes following CAC ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Ocular redness [ Time Frame: Minutes following CAC ]

Original Secondary Outcome: Same as current

Information By: Greiner, Jack V., OD DO PhD

Dates:
Date Received: April 2, 2008
Date Started: February 2008
Date Completion:
Last Updated: April 2, 2008
Last Verified: April 2008